Eleonora Brognara
Overview
Explore the profile of Eleonora Brognara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milani R, Brognara E, Fabbri E, Manicardi A, Corradini R, Finotti A, et al.
Int J Oncol
. 2019 Jun;
55(1):59-68.
PMID: 31180529
The present study investigated the effects of the combined treatment of two peptide nucleic acids (PNAs), directed against microRNAs involved in caspase‑3 mRNA regulation (miR‑155‑5p and miR‑221‑3p) in the temozolomide...
2.
Milani R, Brognara E, Fabbri E, Finotti A, Borgatti M, Lampronti I, et al.
Oncol Res
. 2017 May;
26(9):1307-1315.
PMID: 28474573
Glioblastoma multiforme (GBM), a malignant tumor of the central nervous system, has a high mortality rate. No curative treatment is presently available, and the most commonly used chemotherapeutic drug, the...
3.
Gambari R, Brognara E, Spandidos D, Fabbri E
Int J Oncol
. 2016 May;
49(1):5-32.
PMID: 27175518
MicroRNA (miRNA or miR) therapeutics in cancer are based on targeting or mimicking miRNAs involved in cancer onset, progression, angiogenesis, epithelial-mesenchymal transition and metastasis. Several studies conclusively have demonstrated that...
4.
Brognara E, Fabbri E, Montagner G, Gasparello J, Manicardi A, Corradini R, et al.
Int J Oncol
. 2015 Dec;
48(3):1029-38.
PMID: 26708164
The biological activity of a combined treatment of U251, U373 and T98G glioma cell lines with two anti-miR PNAs, directed against miR‑221 and miR‑222 and conjugated with an ocataarginine tail...
5.
Fabbri E, Brognara E, Montagner G, Ghimenton C, Eccher A, Cantu C, et al.
BMC Cancer
. 2015 Oct;
15:661.
PMID: 26449498
Background: Different strategies have been proposed to target neoangiogenesis in gliomas, besides those targeting Vascular Endothelial Growth Factor (VEGF). The chemokine Interleukin-8 (IL-8) has been shown to possess both tumorigenic...
6.
Bertucci A, Prasetyanto E, Septiadi D, Manicardi A, Brognara E, Gambari R, et al.
Small
. 2015 Sep;
11(42):5687-95.
PMID: 26395266
Mesoporous silica nanoparticles (MSNPs), 100 nm in size, incorporating a Cy5 fluorophore within the silica framework, are synthesized and loaded with the anti-cancer drug temozolomide (TMZ), used in the treatment...
7.
Bianchi N, Finotti A, Ferracin M, Lampronti I, Zuccato C, Breveglieri G, et al.
PLoS One
. 2015 Apr;
10(4):e0121567.
PMID: 25849663
Expression and regulation of microRNAs is an emerging issue in erythroid differentiation and globin gene expression in hemoglobin disorders. In the first part of this study microarray analysis was performed...
8.
Statti G, Marrelli M, Conforti F, Spagnoletti A, Tacchini M, Fimognari C, et al.
Phytother Res
. 2015 Mar;
29(6):857-63.
PMID: 25753739
Indian Sarsaparilla (Hemidesmus indicus R. Br.) is widely used in Indian traditional medicine. In the present work, we explored the effects of decoction, traditional Ayurvedic preparation, and hydroalcoholic extract, a...
9.
Brognara E, Fabbri E, Bazzoli E, Montagner G, Ghimenton C, Eccher A, et al.
J Neurooncol
. 2014 Mar;
118(1):19-28.
PMID: 24595467
MicroRNAs are a family of small noncoding RNAs regulating gene expression by sequence-selective mRNA targeting, leading to a translational repression or mRNA degradation. The oncomiR miR-221 is highly expressed in...
10.
Brognara E, Fabbri E, Bianchi N, Finotti A, Corradini R, Gambari R
Methods Mol Biol
. 2013 Oct;
1095:165-76.
PMID: 24166312
The involvement of microRNAs in human pathologies is a firmly established fact. Accordingly, the pharmacological modulation of their activity appears to be a very appealing issue in the development of...